
Novozymes A/S
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Novozymes A/S is a global biotechnology firm that specializes in the creation and distribution of industrial enzymes, microorganisms, and probiotics. Its operational footprint spans across Europe, the...
Latest News
2 months ago · zacks.com
FUL or NVZMY: Which Is the Better Value Stock Right Now?Investors looking for stocks in the Chemical - Specialty sector might want to consider either H. B. Fuller (FUL) or Novozymes A/S (NVZMY).
2 months ago · seekingalpha.com
Novozymes A/S (NVZMY) Q2 2026 Earnings Call TranscriptNovozymes A/S (NVZMY) Q2 2026 Earnings Call Transcript
3 months ago · zacks.com
FUL vs. NVZMY: Which Stock Is the Better Value Option?Investors interested in Chemical - Specialty stocks are likely familiar with H. B. Fuller (FUL) and Novozymes A/S (NVZMY).
Add to Watchlist
Select watchlists to add or remove NVZMY